✦ LIBER ✦

191 IMMUNOSUPPRESSION WITH SIROLIMUS INCREASES CARDIOVASCULAR RISK IN LIVER TRANSPLANT RECIPIENTS

✍ Scribed by I.B. Doycheva; C.A. Couto; C.L. Gelape; J.K. Kish; P. Martin; C. Levy

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Multicentric outcome analysis of sirolim

✍ Michele Molinari; Kenneth Berman; Glenda Meeberg; James A. Shapiro; David Bigam; 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 366 KB

Cardiovascular risk factors in liver all

✍ E Varo; E Padin; E Otero; S Tomé; J.F Castroagudin; M Delgado; R Conde; F.R Sega 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 52 KB

Limiting Hepatitis C Virus Progression i

✍ G. J. McKenna; J. F. Trotter; E. Klintmalm; N. Onaca; R. Ruiz; L. W. Jennings; M 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 381 KB

Sirolimus-Based Immunosuppressive Therap

✍ Y.J. Yang; D.Z. Chen; L.X. Li; J.T. Kou; R. Lang; Z.K. Jin; D.D. Han; Q. He 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 86 KB

Initial Immunosuppression in Liver Trans

✍ E. Varo; A. López; C. Rivero 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 67 KB

Increased risk of venous thromboembolism

✍ Vivek N. Ahya; Pamela J. McShane; Maher A. Baz; Vincent G. Valentine; Selim M. A 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 290 KB